AI-native architecture
MCP-ready analytical tools the copilot discovers and chains autonomously. Agentic execution with full reasoning traces.
HLA-Compass
Ask a question. The copilot queries proprietary HLA data, picks the right MCP tool, and runs a governed analysis — so you can discover neoantigens in minutes, not months.
How it works
Describe your research question — the copilot understands immunopeptidomics terminology, your data context, and available tools.
The copilot reads MCP descriptors from the tool marketplace, selects the right analytical module, configures inputs, and plans the execution.
Every action is logged, budget-controlled, and traceable. You get results with full provenance — which data, which tool, which model.
AI Copilot Playground
Interact with our autonomous immunopeptidomics assistant. Select a prompt preset below, or type a custom question to see how the AI Copilot maps datasets and executes governed MCP tools in real-time.
Most AI tools hallucinate on domain questions. HLA-Compass is grounded in proprietary data, governed by design, and built for pharma.
MCP-ready analytical tools the copilot discovers and chains autonomously. Agentic execution with full reasoning traces.
1.56 million HLA peptides across 4,425 samples from healthy organs, tumor tissues, and cell lines — evidence from real immunopeptidomics, not sequence prediction alone.
Immutable audit trail, row-level data isolation, credit-based billing, and supply chain attestation on every module.
Different approaches win for different jobs. Public atlases are better for open, citable reference checks, prediction tools are faster for sequence ranking, specialist services are stronger for bespoke wet-lab programs, and in-house stacks maximize control at the cost of time.
| Feature | HLA-Compass | Public atlases HLA Ligand Atlas / SysteMHC Atlas | Prediction tools NetMHCpan / MHCflurry | Specialist services Pure MHC / CRO workflows | In-house stack |
|---|---|---|---|---|---|
| Experimentally observed HLA peptides | If instrumented | ||||
| Open/public reference access | |||||
| Private workspace for proprietary programs | Project-based | ||||
| Healthy tissue context for off-target review | Partial | Partial | Partial | ||
| Self-serve interactive usage | Partial | ||||
| Governed execution / audit layer | Possible | ||||
| Custom workflow control | Partial | Partial | |||
| Time to first result | Immediate | Immediate | Immediate | Weeks | Months |
Representative alternatives used here: HLA Ligand Atlas, SysteMHC Atlas, NetMHCpan/MHCflurry, and specialist discovery-service workflows such as Pure MHC.
No published science entries yet.